Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Erasca, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- −6 vs. Q1 2023
- Shares held
- 74.3M
- −3.66M (−4.7%) vs. Q1 2023
- Total value
- $205.2M
- −$29.7M (−12.7%) vs. Q1 2023
- New holders
- 11
- 46 more added
- Sold out
- 17
- 28 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $5.13B |
| Q1 2026 | 225 | $4.39B |
| Q4 2025 | 154 | $815.7M |
| Q3 2025 | 141 | $468.5M |
| Q2 2025 | 142 | $277.1M |
| Q1 2025 | 154 | $307.3M |
| Q4 2024 | 146 | $579.5M |
| Q3 2024 | 132 | $633.4M |
| Q2 2024 | 126 | $480.6M |
| Q1 2024 | 108 | $149.7M |
| Q4 2023 | 119 | $147.5M |
| Q3 2023 | 109 | $140.4M |
| Q2 2023 | 112 | $205.2M |
| Q1 2023 | 118 | $234.9M |
| Q4 2022 | 107 | $343.9M |
| Q3 2022 | 88 | $627.9M |
| Q2 2022 | 89 | $428.3M |
| Q1 2022 | 82 | $626.6M |
| Q4 2021 | 63 | $988.0M |
| Q3 2021 | 55 | $919.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1,296,832 | $3.58M | 0.00% | −2,033,736−61.1% | Reduced |
| International Biotechnology Trust PLC | 1,426,000 | $3.92M | 1.19% | 00.0% | Unchanged |
| State Street Corp | 1,489,883 | $4.11M | 0.00% | +220,712+17.4% | Added |
| Prosight Management, LP | 1,557,370 | $4.30M | 1.26% | +378,280+32.1% | Added |
| Geode Capital Management, LLC | 1,615,197 | $4.46M | 0.00% | +91,167+6.0% | Added |
| Artal Group S.A. | 4,721,194 | $13.0M | 0.42% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 4,797,460 | $13.2M | 0.53% | 00.0% | Unchanged |
| Vanguard Group Inc | 6,623,231 | $18.3M | 0.00% | +579,443+9.6% | Added |
| BlackRock Inc. | 6,917,154 | $19.1M | 0.00% | +1,545,305+28.8% | Added |
| Armistice Capital, LLC | 7,856,000 | $21.7M | 0.54% | +506,000+6.9% | Added |
| Cormorant Asset Management, LP | 10,813,246 | $29.8M | 1.70% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 11,055,554 | $30.5M | 18.84% | 00.0% | Unchanged |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −724,056−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −678,441−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −396,549−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −227,400−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −184,826−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −88,275−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −61,600−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −43,969−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −37,880−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −35,498−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −23,306−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,176−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −16,880−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −9,364−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −4,217−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −446−100.0% | Sold out |